Global Apomorphine Hydrochloride Market Growth 2025-2031
The global Apomorphine Hydrochloride market size is predicted to grow from US$ 157 million in 2025 to US$ 206 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and ?-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025. Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%. Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%. Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
LP Information, Inc. (LPI) ' newest research report, the “Apomorphine Hydrochloride Industry Forecast” looks at past sales and reviews total world Apomorphine Hydrochloride sales in 2024, providing a comprehensive analysis by region and market sector of projected Apomorphine Hydrochloride sales for 2025 through 2031. With Apomorphine Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Apomorphine Hydrochloride industry.
This Insight Report provides a comprehensive analysis of the global Apomorphine Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Apomorphine Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Apomorphine Hydrochloride market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Apomorphine Hydrochloride and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Apomorphine Hydrochloride.
This report presents a comprehensive overview, market shares, and growth opportunities of Apomorphine Hydrochloride market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Apomorphine Hydrochloride market?
What factors are driving Apomorphine Hydrochloride market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Apomorphine Hydrochloride market opportunities vary by end market size?
How does Apomorphine Hydrochloride break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and ?-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
The classification of Apomorphine Hydrochloride includes Injection, Tablets, Thinfilm, etc and the proportion of Injection in 2019 is about 89.88%, and the proportion is in decreasing trend from 2020 to 2025. Apomorphine Hydrochloride is widely used through Parkinson Disease and Erectile Dysfunction. The most proportion of Apomorphine Hydrochloride is used for Parkinson Disease, and the sales proportion in 2019 is 89.88%. Europe is the largest consumption place, with a consumption market share nearly 54.19% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 23.69%. Market competition is not intense. Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
LP Information, Inc. (LPI) ' newest research report, the “Apomorphine Hydrochloride Industry Forecast” looks at past sales and reviews total world Apomorphine Hydrochloride sales in 2024, providing a comprehensive analysis by region and market sector of projected Apomorphine Hydrochloride sales for 2025 through 2031. With Apomorphine Hydrochloride sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Apomorphine Hydrochloride industry.
This Insight Report provides a comprehensive analysis of the global Apomorphine Hydrochloride landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Apomorphine Hydrochloride portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Apomorphine Hydrochloride market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Apomorphine Hydrochloride and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Apomorphine Hydrochloride.
This report presents a comprehensive overview, market shares, and growth opportunities of Apomorphine Hydrochloride market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injection
- Tablets
- Thinfilm
- Nasal Powder (Pipeline)
- Parkinson Disease
- Erectile Dysfunction
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Supernus Pharmaceuticals
- Britannia Pharmaceuticals STADA
- Ever Pharma
- Evolan Pharma AB (PharmSwed)
- Tianjin Tianwei Pharmaceutical
- Sunovion
- STADA Arzneimittel
- Aguettant
- Italfarmaco
- Sumitomo Pharma
- Hubei Keyi Pharma
What is the 10-year outlook for the global Apomorphine Hydrochloride market?
What factors are driving Apomorphine Hydrochloride market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Apomorphine Hydrochloride market opportunities vary by end market size?
How does Apomorphine Hydrochloride break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Apomorphine Hydrochloride Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Apomorphine Hydrochloride by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Apomorphine Hydrochloride by Country/Region, 2020, 2024 & 2031
2.2 Apomorphine Hydrochloride Segment by Type
2.2.1 Injection
2.2.2 Tablets
2.2.3 Thinfilm
2.2.4 Nasal Powder (Pipeline)
2.3 Apomorphine Hydrochloride Sales by Type
2.3.1 Global Apomorphine Hydrochloride Sales Market Share by Type (2020-2025)
2.3.2 Global Apomorphine Hydrochloride Revenue and Market Share by Type (2020-2025)
2.3.3 Global Apomorphine Hydrochloride Sale Price by Type (2020-2025)
2.4 Apomorphine Hydrochloride Segment by Application
2.4.1 Parkinson Disease
2.4.2 Erectile Dysfunction
2.5 Apomorphine Hydrochloride Sales by Application
2.5.1 Global Apomorphine Hydrochloride Sale Market Share by Application (2020-2025)
2.5.2 Global Apomorphine Hydrochloride Revenue and Market Share by Application (2020-2025)
2.5.3 Global Apomorphine Hydrochloride Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Apomorphine Hydrochloride Breakdown Data by Company
3.1.1 Global Apomorphine Hydrochloride Annual Sales by Company (2020-2025)
3.1.2 Global Apomorphine Hydrochloride Sales Market Share by Company (2020-2025)
3.2 Global Apomorphine Hydrochloride Annual Revenue by Company (2020-2025)
3.2.1 Global Apomorphine Hydrochloride Revenue by Company (2020-2025)
3.2.2 Global Apomorphine Hydrochloride Revenue Market Share by Company (2020-2025)
3.3 Global Apomorphine Hydrochloride Sale Price by Company
3.4 Key Manufacturers Apomorphine Hydrochloride Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Apomorphine Hydrochloride Product Location Distribution
3.4.2 Players Apomorphine Hydrochloride Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR APOMORPHINE HYDROCHLORIDE BY GEOGRAPHIC REGION
4.1 World Historic Apomorphine Hydrochloride Market Size by Geographic Region (2020-2025)
4.1.1 Global Apomorphine Hydrochloride Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Apomorphine Hydrochloride Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Apomorphine Hydrochloride Market Size by Country/Region (2020-2025)
4.2.1 Global Apomorphine Hydrochloride Annual Sales by Country/Region (2020-2025)
4.2.2 Global Apomorphine Hydrochloride Annual Revenue by Country/Region (2020-2025)
4.3 Americas Apomorphine Hydrochloride Sales Growth
4.4 APAC Apomorphine Hydrochloride Sales Growth
4.5 Europe Apomorphine Hydrochloride Sales Growth
4.6 Middle East & Africa Apomorphine Hydrochloride Sales Growth
5 AMERICAS
5.1 Americas Apomorphine Hydrochloride Sales by Country
5.1.1 Americas Apomorphine Hydrochloride Sales by Country (2020-2025)
5.1.2 Americas Apomorphine Hydrochloride Revenue by Country (2020-2025)
5.2 Americas Apomorphine Hydrochloride Sales by Type (2020-2025)
5.3 Americas Apomorphine Hydrochloride Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Apomorphine Hydrochloride Sales by Region
6.1.1 APAC Apomorphine Hydrochloride Sales by Region (2020-2025)
6.1.2 APAC Apomorphine Hydrochloride Revenue by Region (2020-2025)
6.2 APAC Apomorphine Hydrochloride Sales by Type (2020-2025)
6.3 APAC Apomorphine Hydrochloride Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Apomorphine Hydrochloride by Country
7.1.1 Europe Apomorphine Hydrochloride Sales by Country (2020-2025)
7.1.2 Europe Apomorphine Hydrochloride Revenue by Country (2020-2025)
7.2 Europe Apomorphine Hydrochloride Sales by Type (2020-2025)
7.3 Europe Apomorphine Hydrochloride Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Apomorphine Hydrochloride by Country
8.1.1 Middle East & Africa Apomorphine Hydrochloride Sales by Country (2020-2025)
8.1.2 Middle East & Africa Apomorphine Hydrochloride Revenue by Country (2020-2025)
8.2 Middle East & Africa Apomorphine Hydrochloride Sales by Type (2020-2025)
8.3 Middle East & Africa Apomorphine Hydrochloride Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Apomorphine Hydrochloride
10.3 Manufacturing Process Analysis of Apomorphine Hydrochloride
10.4 Industry Chain Structure of Apomorphine Hydrochloride
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Apomorphine Hydrochloride Distributors
11.3 Apomorphine Hydrochloride Customer
12 WORLD FORECAST REVIEW FOR APOMORPHINE HYDROCHLORIDE BY GEOGRAPHIC REGION
12.1 Global Apomorphine Hydrochloride Market Size Forecast by Region
12.1.1 Global Apomorphine Hydrochloride Forecast by Region (2026-2031)
12.1.2 Global Apomorphine Hydrochloride Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Apomorphine Hydrochloride Forecast by Type (2026-2031)
12.7 Global Apomorphine Hydrochloride Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Supernus Pharmaceuticals
13.1.1 Supernus Pharmaceuticals Company Information
13.1.2 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolios and Specifications
13.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Supernus Pharmaceuticals Main Business Overview
13.1.5 Supernus Pharmaceuticals Latest Developments
13.2 Britannia Pharmaceuticals STADA
13.2.1 Britannia Pharmaceuticals STADA Company Information
13.2.2 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolios and Specifications
13.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Britannia Pharmaceuticals STADA Main Business Overview
13.2.5 Britannia Pharmaceuticals STADA Latest Developments
13.3 Ever Pharma
13.3.1 Ever Pharma Company Information
13.3.2 Ever Pharma Apomorphine Hydrochloride Product Portfolios and Specifications
13.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Ever Pharma Main Business Overview
13.3.5 Ever Pharma Latest Developments
13.4 Evolan Pharma AB (PharmSwed)
13.4.1 Evolan Pharma AB (PharmSwed) Company Information
13.4.2 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolios and Specifications
13.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Evolan Pharma AB (PharmSwed) Main Business Overview
13.4.5 Evolan Pharma AB (PharmSwed) Latest Developments
13.5 Tianjin Tianwei Pharmaceutical
13.5.1 Tianjin Tianwei Pharmaceutical Company Information
13.5.2 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolios and Specifications
13.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Tianjin Tianwei Pharmaceutical Main Business Overview
13.5.5 Tianjin Tianwei Pharmaceutical Latest Developments
13.6 Sunovion
13.6.1 Sunovion Company Information
13.6.2 Sunovion Apomorphine Hydrochloride Product Portfolios and Specifications
13.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sunovion Main Business Overview
13.6.5 Sunovion Latest Developments
13.7 STADA Arzneimittel
13.7.1 STADA Arzneimittel Company Information
13.7.2 STADA Arzneimittel Apomorphine Hydrochloride Product Portfolios and Specifications
13.7.3 STADA Arzneimittel Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 STADA Arzneimittel Main Business Overview
13.7.5 STADA Arzneimittel Latest Developments
13.8 Aguettant
13.8.1 Aguettant Company Information
13.8.2 Aguettant Apomorphine Hydrochloride Product Portfolios and Specifications
13.8.3 Aguettant Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Aguettant Main Business Overview
13.8.5 Aguettant Latest Developments
13.9 Italfarmaco
13.9.1 Italfarmaco Company Information
13.9.2 Italfarmaco Apomorphine Hydrochloride Product Portfolios and Specifications
13.9.3 Italfarmaco Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Italfarmaco Main Business Overview
13.9.5 Italfarmaco Latest Developments
13.10 Sumitomo Pharma
13.10.1 Sumitomo Pharma Company Information
13.10.2 Sumitomo Pharma Apomorphine Hydrochloride Product Portfolios and Specifications
13.10.3 Sumitomo Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sumitomo Pharma Main Business Overview
13.10.5 Sumitomo Pharma Latest Developments
13.11 Hubei Keyi Pharma
13.11.1 Hubei Keyi Pharma Company Information
13.11.2 Hubei Keyi Pharma Apomorphine Hydrochloride Product Portfolios and Specifications
13.11.3 Hubei Keyi Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hubei Keyi Pharma Main Business Overview
13.11.5 Hubei Keyi Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Apomorphine Hydrochloride Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Apomorphine Hydrochloride by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Apomorphine Hydrochloride by Country/Region, 2020, 2024 & 2031
2.2 Apomorphine Hydrochloride Segment by Type
2.2.1 Injection
2.2.2 Tablets
2.2.3 Thinfilm
2.2.4 Nasal Powder (Pipeline)
2.3 Apomorphine Hydrochloride Sales by Type
2.3.1 Global Apomorphine Hydrochloride Sales Market Share by Type (2020-2025)
2.3.2 Global Apomorphine Hydrochloride Revenue and Market Share by Type (2020-2025)
2.3.3 Global Apomorphine Hydrochloride Sale Price by Type (2020-2025)
2.4 Apomorphine Hydrochloride Segment by Application
2.4.1 Parkinson Disease
2.4.2 Erectile Dysfunction
2.5 Apomorphine Hydrochloride Sales by Application
2.5.1 Global Apomorphine Hydrochloride Sale Market Share by Application (2020-2025)
2.5.2 Global Apomorphine Hydrochloride Revenue and Market Share by Application (2020-2025)
2.5.3 Global Apomorphine Hydrochloride Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Apomorphine Hydrochloride Breakdown Data by Company
3.1.1 Global Apomorphine Hydrochloride Annual Sales by Company (2020-2025)
3.1.2 Global Apomorphine Hydrochloride Sales Market Share by Company (2020-2025)
3.2 Global Apomorphine Hydrochloride Annual Revenue by Company (2020-2025)
3.2.1 Global Apomorphine Hydrochloride Revenue by Company (2020-2025)
3.2.2 Global Apomorphine Hydrochloride Revenue Market Share by Company (2020-2025)
3.3 Global Apomorphine Hydrochloride Sale Price by Company
3.4 Key Manufacturers Apomorphine Hydrochloride Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Apomorphine Hydrochloride Product Location Distribution
3.4.2 Players Apomorphine Hydrochloride Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR APOMORPHINE HYDROCHLORIDE BY GEOGRAPHIC REGION
4.1 World Historic Apomorphine Hydrochloride Market Size by Geographic Region (2020-2025)
4.1.1 Global Apomorphine Hydrochloride Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Apomorphine Hydrochloride Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Apomorphine Hydrochloride Market Size by Country/Region (2020-2025)
4.2.1 Global Apomorphine Hydrochloride Annual Sales by Country/Region (2020-2025)
4.2.2 Global Apomorphine Hydrochloride Annual Revenue by Country/Region (2020-2025)
4.3 Americas Apomorphine Hydrochloride Sales Growth
4.4 APAC Apomorphine Hydrochloride Sales Growth
4.5 Europe Apomorphine Hydrochloride Sales Growth
4.6 Middle East & Africa Apomorphine Hydrochloride Sales Growth
5 AMERICAS
5.1 Americas Apomorphine Hydrochloride Sales by Country
5.1.1 Americas Apomorphine Hydrochloride Sales by Country (2020-2025)
5.1.2 Americas Apomorphine Hydrochloride Revenue by Country (2020-2025)
5.2 Americas Apomorphine Hydrochloride Sales by Type (2020-2025)
5.3 Americas Apomorphine Hydrochloride Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Apomorphine Hydrochloride Sales by Region
6.1.1 APAC Apomorphine Hydrochloride Sales by Region (2020-2025)
6.1.2 APAC Apomorphine Hydrochloride Revenue by Region (2020-2025)
6.2 APAC Apomorphine Hydrochloride Sales by Type (2020-2025)
6.3 APAC Apomorphine Hydrochloride Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Apomorphine Hydrochloride by Country
7.1.1 Europe Apomorphine Hydrochloride Sales by Country (2020-2025)
7.1.2 Europe Apomorphine Hydrochloride Revenue by Country (2020-2025)
7.2 Europe Apomorphine Hydrochloride Sales by Type (2020-2025)
7.3 Europe Apomorphine Hydrochloride Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Apomorphine Hydrochloride by Country
8.1.1 Middle East & Africa Apomorphine Hydrochloride Sales by Country (2020-2025)
8.1.2 Middle East & Africa Apomorphine Hydrochloride Revenue by Country (2020-2025)
8.2 Middle East & Africa Apomorphine Hydrochloride Sales by Type (2020-2025)
8.3 Middle East & Africa Apomorphine Hydrochloride Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Apomorphine Hydrochloride
10.3 Manufacturing Process Analysis of Apomorphine Hydrochloride
10.4 Industry Chain Structure of Apomorphine Hydrochloride
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Apomorphine Hydrochloride Distributors
11.3 Apomorphine Hydrochloride Customer
12 WORLD FORECAST REVIEW FOR APOMORPHINE HYDROCHLORIDE BY GEOGRAPHIC REGION
12.1 Global Apomorphine Hydrochloride Market Size Forecast by Region
12.1.1 Global Apomorphine Hydrochloride Forecast by Region (2026-2031)
12.1.2 Global Apomorphine Hydrochloride Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Apomorphine Hydrochloride Forecast by Type (2026-2031)
12.7 Global Apomorphine Hydrochloride Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Supernus Pharmaceuticals
13.1.1 Supernus Pharmaceuticals Company Information
13.1.2 Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolios and Specifications
13.1.3 Supernus Pharmaceuticals Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Supernus Pharmaceuticals Main Business Overview
13.1.5 Supernus Pharmaceuticals Latest Developments
13.2 Britannia Pharmaceuticals STADA
13.2.1 Britannia Pharmaceuticals STADA Company Information
13.2.2 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolios and Specifications
13.2.3 Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Britannia Pharmaceuticals STADA Main Business Overview
13.2.5 Britannia Pharmaceuticals STADA Latest Developments
13.3 Ever Pharma
13.3.1 Ever Pharma Company Information
13.3.2 Ever Pharma Apomorphine Hydrochloride Product Portfolios and Specifications
13.3.3 Ever Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Ever Pharma Main Business Overview
13.3.5 Ever Pharma Latest Developments
13.4 Evolan Pharma AB (PharmSwed)
13.4.1 Evolan Pharma AB (PharmSwed) Company Information
13.4.2 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolios and Specifications
13.4.3 Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Evolan Pharma AB (PharmSwed) Main Business Overview
13.4.5 Evolan Pharma AB (PharmSwed) Latest Developments
13.5 Tianjin Tianwei Pharmaceutical
13.5.1 Tianjin Tianwei Pharmaceutical Company Information
13.5.2 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolios and Specifications
13.5.3 Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Tianjin Tianwei Pharmaceutical Main Business Overview
13.5.5 Tianjin Tianwei Pharmaceutical Latest Developments
13.6 Sunovion
13.6.1 Sunovion Company Information
13.6.2 Sunovion Apomorphine Hydrochloride Product Portfolios and Specifications
13.6.3 Sunovion Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sunovion Main Business Overview
13.6.5 Sunovion Latest Developments
13.7 STADA Arzneimittel
13.7.1 STADA Arzneimittel Company Information
13.7.2 STADA Arzneimittel Apomorphine Hydrochloride Product Portfolios and Specifications
13.7.3 STADA Arzneimittel Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 STADA Arzneimittel Main Business Overview
13.7.5 STADA Arzneimittel Latest Developments
13.8 Aguettant
13.8.1 Aguettant Company Information
13.8.2 Aguettant Apomorphine Hydrochloride Product Portfolios and Specifications
13.8.3 Aguettant Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Aguettant Main Business Overview
13.8.5 Aguettant Latest Developments
13.9 Italfarmaco
13.9.1 Italfarmaco Company Information
13.9.2 Italfarmaco Apomorphine Hydrochloride Product Portfolios and Specifications
13.9.3 Italfarmaco Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Italfarmaco Main Business Overview
13.9.5 Italfarmaco Latest Developments
13.10 Sumitomo Pharma
13.10.1 Sumitomo Pharma Company Information
13.10.2 Sumitomo Pharma Apomorphine Hydrochloride Product Portfolios and Specifications
13.10.3 Sumitomo Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sumitomo Pharma Main Business Overview
13.10.5 Sumitomo Pharma Latest Developments
13.11 Hubei Keyi Pharma
13.11.1 Hubei Keyi Pharma Company Information
13.11.2 Hubei Keyi Pharma Apomorphine Hydrochloride Product Portfolios and Specifications
13.11.3 Hubei Keyi Pharma Apomorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hubei Keyi Pharma Main Business Overview
13.11.5 Hubei Keyi Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Apomorphine Hydrochloride Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Apomorphine Hydrochloride Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players ofTablets
Table 5. Major Players of Thinfilm
Table 6. Major Players of Nasal Powder (Pipeline)
Table 7. Global Apomorphine Hydrochloride Sales by Type (2020-2025) & (K Units)
Table 8. Global Apomorphine Hydrochloride Sales Market Share by Type (2020-2025)
Table 9. Global Apomorphine Hydrochloride Revenue by Type (2020-2025) & ($ million)
Table 10. Global Apomorphine Hydrochloride Revenue Market Share by Type (2020-2025)
Table 11. Global Apomorphine Hydrochloride Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Apomorphine Hydrochloride Sale by Application (2020-2025) & (K Units)
Table 13. Global Apomorphine Hydrochloride Sale Market Share by Application (2020-2025)
Table 14. Global Apomorphine Hydrochloride Revenue by Application (2020-2025) & ($ million)
Table 15. Global Apomorphine Hydrochloride Revenue Market Share by Application (2020-2025)
Table 16. Global Apomorphine Hydrochloride Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Apomorphine Hydrochloride Sales by Company (2020-2025) & (K Units)
Table 18. Global Apomorphine Hydrochloride Sales Market Share by Company (2020-2025)
Table 19. Global Apomorphine Hydrochloride Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Apomorphine Hydrochloride Revenue Market Share by Company (2020-2025)
Table 21. Global Apomorphine Hydrochloride Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Apomorphine Hydrochloride Producing Area Distribution and Sales Area
Table 23. Players Apomorphine Hydrochloride Products Offered
Table 24. Apomorphine Hydrochloride Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Apomorphine Hydrochloride Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Apomorphine Hydrochloride Sales Market Share Geographic Region (2020-2025)
Table 29. Global Apomorphine Hydrochloride Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Apomorphine Hydrochloride Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Apomorphine Hydrochloride Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Apomorphine Hydrochloride Sales Market Share by Country/Region (2020-2025)
Table 33. Global Apomorphine Hydrochloride Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Apomorphine Hydrochloride Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Apomorphine Hydrochloride Sales by Country (2020-2025) & (K Units)
Table 36. Americas Apomorphine Hydrochloride Sales Market Share by Country (2020-2025)
Table 37. Americas Apomorphine Hydrochloride Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Apomorphine Hydrochloride Sales by Type (2020-2025) & (K Units)
Table 39. Americas Apomorphine Hydrochloride Sales by Application (2020-2025) & (K Units)
Table 40. APAC Apomorphine Hydrochloride Sales by Region (2020-2025) & (K Units)
Table 41. APAC Apomorphine Hydrochloride Sales Market Share by Region (2020-2025)
Table 42. APAC Apomorphine Hydrochloride Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Apomorphine Hydrochloride Sales by Type (2020-2025) & (K Units)
Table 44. APAC Apomorphine Hydrochloride Sales by Application (2020-2025) & (K Units)
Table 45. Europe Apomorphine Hydrochloride Sales by Country (2020-2025) & (K Units)
Table 46. Europe Apomorphine Hydrochloride Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Apomorphine Hydrochloride Sales by Type (2020-2025) & (K Units)
Table 48. Europe Apomorphine Hydrochloride Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Apomorphine Hydrochloride Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Apomorphine Hydrochloride Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Apomorphine Hydrochloride Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Apomorphine Hydrochloride Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Apomorphine Hydrochloride
Table 54. Key Market Challenges & Risks of Apomorphine Hydrochloride
Table 55. Key Industry Trends of Apomorphine Hydrochloride
Table 56. Apomorphine Hydrochloride Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Apomorphine Hydrochloride Distributors List
Table 59. Apomorphine Hydrochloride Customer List
Table 60. Global Apomorphine Hydrochloride Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Apomorphine Hydrochloride Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Apomorphine Hydrochloride Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Apomorphine Hydrochloride Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Apomorphine Hydrochloride Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Apomorphine Hydrochloride Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Apomorphine Hydrochloride Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Apomorphine Hydrochloride Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Apomorphine Hydrochloride Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Apomorphine Hydrochloride Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Apomorphine Hydrochloride Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Apomorphine Hydrochloride Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Apomorphine Hydrochloride Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Apomorphine Hydrochloride Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Supernus Pharmaceuticals Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 75. Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolios and Specifications
Table 76. Supernus Pharmaceuticals Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Supernus Pharmaceuticals Main Business
Table 78. Supernus Pharmaceuticals Latest Developments
Table 79. Britannia Pharmaceuticals STADA Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 80. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolios and Specifications
Table 81. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Britannia Pharmaceuticals STADA Main Business
Table 83. Britannia Pharmaceuticals STADA Latest Developments
Table 84. Ever Pharma Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 85. Ever Pharma Apomorphine Hydrochloride Product Portfolios and Specifications
Table 86. Ever Pharma Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Ever Pharma Main Business
Table 88. Ever Pharma Latest Developments
Table 89. Evolan Pharma AB (PharmSwed) Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 90. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolios and Specifications
Table 91. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Evolan Pharma AB (PharmSwed) Main Business
Table 93. Evolan Pharma AB (PharmSwed) Latest Developments
Table 94. Tianjin Tianwei Pharmaceutical Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 95. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolios and Specifications
Table 96. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Tianjin Tianwei Pharmaceutical Main Business
Table 98. Tianjin Tianwei Pharmaceutical Latest Developments
Table 99. Sunovion Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 100. Sunovion Apomorphine Hydrochloride Product Portfolios and Specifications
Table 101. Sunovion Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Sunovion Main Business
Table 103. Sunovion Latest Developments
Table 104. STADA Arzneimittel Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 105. STADA Arzneimittel Apomorphine Hydrochloride Product Portfolios and Specifications
Table 106. STADA Arzneimittel Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. STADA Arzneimittel Main Business
Table 108. STADA Arzneimittel Latest Developments
Table 109. Aguettant Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 110. Aguettant Apomorphine Hydrochloride Product Portfolios and Specifications
Table 111. Aguettant Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Aguettant Main Business
Table 113. Aguettant Latest Developments
Table 114. Italfarmaco Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 115. Italfarmaco Apomorphine Hydrochloride Product Portfolios and Specifications
Table 116. Italfarmaco Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Italfarmaco Main Business
Table 118. Italfarmaco Latest Developments
Table 119. Sumitomo Pharma Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 120. Sumitomo Pharma Apomorphine Hydrochloride Product Portfolios and Specifications
Table 121. Sumitomo Pharma Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Sumitomo Pharma Main Business
Table 123. Sumitomo Pharma Latest Developments
Table 124. Hubei Keyi Pharma Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 125. Hubei Keyi Pharma Apomorphine Hydrochloride Product Portfolios and Specifications
Table 126. Hubei Keyi Pharma Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Hubei Keyi Pharma Main Business
Table 128. Hubei Keyi Pharma Latest Developments
Table 1. Apomorphine Hydrochloride Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Apomorphine Hydrochloride Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players ofTablets
Table 5. Major Players of Thinfilm
Table 6. Major Players of Nasal Powder (Pipeline)
Table 7. Global Apomorphine Hydrochloride Sales by Type (2020-2025) & (K Units)
Table 8. Global Apomorphine Hydrochloride Sales Market Share by Type (2020-2025)
Table 9. Global Apomorphine Hydrochloride Revenue by Type (2020-2025) & ($ million)
Table 10. Global Apomorphine Hydrochloride Revenue Market Share by Type (2020-2025)
Table 11. Global Apomorphine Hydrochloride Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Apomorphine Hydrochloride Sale by Application (2020-2025) & (K Units)
Table 13. Global Apomorphine Hydrochloride Sale Market Share by Application (2020-2025)
Table 14. Global Apomorphine Hydrochloride Revenue by Application (2020-2025) & ($ million)
Table 15. Global Apomorphine Hydrochloride Revenue Market Share by Application (2020-2025)
Table 16. Global Apomorphine Hydrochloride Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Apomorphine Hydrochloride Sales by Company (2020-2025) & (K Units)
Table 18. Global Apomorphine Hydrochloride Sales Market Share by Company (2020-2025)
Table 19. Global Apomorphine Hydrochloride Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Apomorphine Hydrochloride Revenue Market Share by Company (2020-2025)
Table 21. Global Apomorphine Hydrochloride Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Apomorphine Hydrochloride Producing Area Distribution and Sales Area
Table 23. Players Apomorphine Hydrochloride Products Offered
Table 24. Apomorphine Hydrochloride Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Apomorphine Hydrochloride Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Apomorphine Hydrochloride Sales Market Share Geographic Region (2020-2025)
Table 29. Global Apomorphine Hydrochloride Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Apomorphine Hydrochloride Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Apomorphine Hydrochloride Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Apomorphine Hydrochloride Sales Market Share by Country/Region (2020-2025)
Table 33. Global Apomorphine Hydrochloride Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Apomorphine Hydrochloride Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Apomorphine Hydrochloride Sales by Country (2020-2025) & (K Units)
Table 36. Americas Apomorphine Hydrochloride Sales Market Share by Country (2020-2025)
Table 37. Americas Apomorphine Hydrochloride Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Apomorphine Hydrochloride Sales by Type (2020-2025) & (K Units)
Table 39. Americas Apomorphine Hydrochloride Sales by Application (2020-2025) & (K Units)
Table 40. APAC Apomorphine Hydrochloride Sales by Region (2020-2025) & (K Units)
Table 41. APAC Apomorphine Hydrochloride Sales Market Share by Region (2020-2025)
Table 42. APAC Apomorphine Hydrochloride Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Apomorphine Hydrochloride Sales by Type (2020-2025) & (K Units)
Table 44. APAC Apomorphine Hydrochloride Sales by Application (2020-2025) & (K Units)
Table 45. Europe Apomorphine Hydrochloride Sales by Country (2020-2025) & (K Units)
Table 46. Europe Apomorphine Hydrochloride Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Apomorphine Hydrochloride Sales by Type (2020-2025) & (K Units)
Table 48. Europe Apomorphine Hydrochloride Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Apomorphine Hydrochloride Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Apomorphine Hydrochloride Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Apomorphine Hydrochloride Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Apomorphine Hydrochloride Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Apomorphine Hydrochloride
Table 54. Key Market Challenges & Risks of Apomorphine Hydrochloride
Table 55. Key Industry Trends of Apomorphine Hydrochloride
Table 56. Apomorphine Hydrochloride Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Apomorphine Hydrochloride Distributors List
Table 59. Apomorphine Hydrochloride Customer List
Table 60. Global Apomorphine Hydrochloride Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Apomorphine Hydrochloride Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Apomorphine Hydrochloride Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Apomorphine Hydrochloride Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Apomorphine Hydrochloride Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Apomorphine Hydrochloride Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Apomorphine Hydrochloride Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Apomorphine Hydrochloride Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Apomorphine Hydrochloride Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Apomorphine Hydrochloride Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Apomorphine Hydrochloride Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Apomorphine Hydrochloride Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Apomorphine Hydrochloride Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Apomorphine Hydrochloride Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Supernus Pharmaceuticals Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 75. Supernus Pharmaceuticals Apomorphine Hydrochloride Product Portfolios and Specifications
Table 76. Supernus Pharmaceuticals Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Supernus Pharmaceuticals Main Business
Table 78. Supernus Pharmaceuticals Latest Developments
Table 79. Britannia Pharmaceuticals STADA Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 80. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Product Portfolios and Specifications
Table 81. Britannia Pharmaceuticals STADA Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Britannia Pharmaceuticals STADA Main Business
Table 83. Britannia Pharmaceuticals STADA Latest Developments
Table 84. Ever Pharma Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 85. Ever Pharma Apomorphine Hydrochloride Product Portfolios and Specifications
Table 86. Ever Pharma Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Ever Pharma Main Business
Table 88. Ever Pharma Latest Developments
Table 89. Evolan Pharma AB (PharmSwed) Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 90. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Product Portfolios and Specifications
Table 91. Evolan Pharma AB (PharmSwed) Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Evolan Pharma AB (PharmSwed) Main Business
Table 93. Evolan Pharma AB (PharmSwed) Latest Developments
Table 94. Tianjin Tianwei Pharmaceutical Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 95. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Product Portfolios and Specifications
Table 96. Tianjin Tianwei Pharmaceutical Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Tianjin Tianwei Pharmaceutical Main Business
Table 98. Tianjin Tianwei Pharmaceutical Latest Developments
Table 99. Sunovion Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 100. Sunovion Apomorphine Hydrochloride Product Portfolios and Specifications
Table 101. Sunovion Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Sunovion Main Business
Table 103. Sunovion Latest Developments
Table 104. STADA Arzneimittel Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 105. STADA Arzneimittel Apomorphine Hydrochloride Product Portfolios and Specifications
Table 106. STADA Arzneimittel Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. STADA Arzneimittel Main Business
Table 108. STADA Arzneimittel Latest Developments
Table 109. Aguettant Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 110. Aguettant Apomorphine Hydrochloride Product Portfolios and Specifications
Table 111. Aguettant Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Aguettant Main Business
Table 113. Aguettant Latest Developments
Table 114. Italfarmaco Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 115. Italfarmaco Apomorphine Hydrochloride Product Portfolios and Specifications
Table 116. Italfarmaco Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Italfarmaco Main Business
Table 118. Italfarmaco Latest Developments
Table 119. Sumitomo Pharma Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 120. Sumitomo Pharma Apomorphine Hydrochloride Product Portfolios and Specifications
Table 121. Sumitomo Pharma Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Sumitomo Pharma Main Business
Table 123. Sumitomo Pharma Latest Developments
Table 124. Hubei Keyi Pharma Basic Information, Apomorphine Hydrochloride Manufacturing Base, Sales Area and Its Competitors
Table 125. Hubei Keyi Pharma Apomorphine Hydrochloride Product Portfolios and Specifications
Table 126. Hubei Keyi Pharma Apomorphine Hydrochloride Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Hubei Keyi Pharma Main Business
Table 128. Hubei Keyi Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Apomorphine Hydrochloride
Figure 2. Apomorphine Hydrochloride Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Apomorphine Hydrochloride Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Apomorphine Hydrochloride Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Apomorphine Hydrochloride Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Apomorphine Hydrochloride Sales Market Share by Country/Region (2024)
Figure 10. Apomorphine Hydrochloride Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection
Figure 12. Product Picture ofTablets
Figure 13. Product Picture of Thinfilm
Figure 14. Product Picture of Nasal Powder (Pipeline)
Figure 15. Global Apomorphine Hydrochloride Sales Market Share by Type in 2025
Figure 16. Global Apomorphine Hydrochloride Revenue Market Share by Type (2020-2025)
Figure 17. Apomorphine Hydrochloride Consumed in Parkinson Disease
Figure 18. Global Apomorphine Hydrochloride Market: Parkinson Disease (2020-2025) & (K Units)
Figure 19. Apomorphine Hydrochloride Consumed in Erectile Dysfunction
Figure 20. Global Apomorphine Hydrochloride Market: Erectile Dysfunction (2020-2025) & (K Units)
Figure 21. Global Apomorphine Hydrochloride Sale Market Share by Application (2024)
Figure 22. Global Apomorphine Hydrochloride Revenue Market Share by Application in 2025
Figure 23. Apomorphine Hydrochloride Sales by Company in 2025 (K Units)
Figure 24. Global Apomorphine Hydrochloride Sales Market Share by Company in 2025
Figure 25. Apomorphine Hydrochloride Revenue by Company in 2025 ($ millions)
Figure 26. Global Apomorphine Hydrochloride Revenue Market Share by Company in 2025
Figure 27. Global Apomorphine Hydrochloride Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Apomorphine Hydrochloride Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Apomorphine Hydrochloride Sales 2020-2025 (K Units)
Figure 30. Americas Apomorphine Hydrochloride Revenue 2020-2025 ($ millions)
Figure 31. APAC Apomorphine Hydrochloride Sales 2020-2025 (K Units)
Figure 32. APAC Apomorphine Hydrochloride Revenue 2020-2025 ($ millions)
Figure 33. Europe Apomorphine Hydrochloride Sales 2020-2025 (K Units)
Figure 34. Europe Apomorphine Hydrochloride Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Apomorphine Hydrochloride Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Apomorphine Hydrochloride Revenue 2020-2025 ($ millions)
Figure 37. Americas Apomorphine Hydrochloride Sales Market Share by Country in 2025
Figure 38. Americas Apomorphine Hydrochloride Revenue Market Share by Country (2020-2025)
Figure 39. Americas Apomorphine Hydrochloride Sales Market Share by Type (2020-2025)
Figure 40. Americas Apomorphine Hydrochloride Sales Market Share by Application (2020-2025)
Figure 41. United States Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Apomorphine Hydrochloride Sales Market Share by Region in 2025
Figure 46. APAC Apomorphine Hydrochloride Revenue Market Share by Region (2020-2025)
Figure 47. APAC Apomorphine Hydrochloride Sales Market Share by Type (2020-2025)
Figure 48. APAC Apomorphine Hydrochloride Sales Market Share by Application (2020-2025)
Figure 49. China Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 53. India Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Apomorphine Hydrochloride Sales Market Share by Country in 2025
Figure 57. Europe Apomorphine Hydrochloride Revenue Market Share by Country (2020-2025)
Figure 58. Europe Apomorphine Hydrochloride Sales Market Share by Type (2020-2025)
Figure 59. Europe Apomorphine Hydrochloride Sales Market Share by Application (2020-2025)
Figure 60. Germany Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 61. France Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Apomorphine Hydrochloride Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Apomorphine Hydrochloride Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Apomorphine Hydrochloride Sales Market Share by Application (2020-2025)
Figure 68. Egypt Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Apomorphine Hydrochloride in 2025
Figure 74. Manufacturing Process Analysis of Apomorphine Hydrochloride
Figure 75. Industry Chain Structure of Apomorphine Hydrochloride
Figure 76. Channels of Distribution
Figure 77. Global Apomorphine Hydrochloride Sales Market Forecast by Region (2026-2031)
Figure 78. Global Apomorphine Hydrochloride Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Apomorphine Hydrochloride Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Apomorphine Hydrochloride Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Apomorphine Hydrochloride Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Apomorphine Hydrochloride Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Apomorphine Hydrochloride
Figure 2. Apomorphine Hydrochloride Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Apomorphine Hydrochloride Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Apomorphine Hydrochloride Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Apomorphine Hydrochloride Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Apomorphine Hydrochloride Sales Market Share by Country/Region (2024)
Figure 10. Apomorphine Hydrochloride Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Injection
Figure 12. Product Picture ofTablets
Figure 13. Product Picture of Thinfilm
Figure 14. Product Picture of Nasal Powder (Pipeline)
Figure 15. Global Apomorphine Hydrochloride Sales Market Share by Type in 2025
Figure 16. Global Apomorphine Hydrochloride Revenue Market Share by Type (2020-2025)
Figure 17. Apomorphine Hydrochloride Consumed in Parkinson Disease
Figure 18. Global Apomorphine Hydrochloride Market: Parkinson Disease (2020-2025) & (K Units)
Figure 19. Apomorphine Hydrochloride Consumed in Erectile Dysfunction
Figure 20. Global Apomorphine Hydrochloride Market: Erectile Dysfunction (2020-2025) & (K Units)
Figure 21. Global Apomorphine Hydrochloride Sale Market Share by Application (2024)
Figure 22. Global Apomorphine Hydrochloride Revenue Market Share by Application in 2025
Figure 23. Apomorphine Hydrochloride Sales by Company in 2025 (K Units)
Figure 24. Global Apomorphine Hydrochloride Sales Market Share by Company in 2025
Figure 25. Apomorphine Hydrochloride Revenue by Company in 2025 ($ millions)
Figure 26. Global Apomorphine Hydrochloride Revenue Market Share by Company in 2025
Figure 27. Global Apomorphine Hydrochloride Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Apomorphine Hydrochloride Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Apomorphine Hydrochloride Sales 2020-2025 (K Units)
Figure 30. Americas Apomorphine Hydrochloride Revenue 2020-2025 ($ millions)
Figure 31. APAC Apomorphine Hydrochloride Sales 2020-2025 (K Units)
Figure 32. APAC Apomorphine Hydrochloride Revenue 2020-2025 ($ millions)
Figure 33. Europe Apomorphine Hydrochloride Sales 2020-2025 (K Units)
Figure 34. Europe Apomorphine Hydrochloride Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Apomorphine Hydrochloride Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Apomorphine Hydrochloride Revenue 2020-2025 ($ millions)
Figure 37. Americas Apomorphine Hydrochloride Sales Market Share by Country in 2025
Figure 38. Americas Apomorphine Hydrochloride Revenue Market Share by Country (2020-2025)
Figure 39. Americas Apomorphine Hydrochloride Sales Market Share by Type (2020-2025)
Figure 40. Americas Apomorphine Hydrochloride Sales Market Share by Application (2020-2025)
Figure 41. United States Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Apomorphine Hydrochloride Sales Market Share by Region in 2025
Figure 46. APAC Apomorphine Hydrochloride Revenue Market Share by Region (2020-2025)
Figure 47. APAC Apomorphine Hydrochloride Sales Market Share by Type (2020-2025)
Figure 48. APAC Apomorphine Hydrochloride Sales Market Share by Application (2020-2025)
Figure 49. China Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 53. India Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Apomorphine Hydrochloride Sales Market Share by Country in 2025
Figure 57. Europe Apomorphine Hydrochloride Revenue Market Share by Country (2020-2025)
Figure 58. Europe Apomorphine Hydrochloride Sales Market Share by Type (2020-2025)
Figure 59. Europe Apomorphine Hydrochloride Sales Market Share by Application (2020-2025)
Figure 60. Germany Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 61. France Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Apomorphine Hydrochloride Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Apomorphine Hydrochloride Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Apomorphine Hydrochloride Sales Market Share by Application (2020-2025)
Figure 68. Egypt Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Apomorphine Hydrochloride Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Apomorphine Hydrochloride in 2025
Figure 74. Manufacturing Process Analysis of Apomorphine Hydrochloride
Figure 75. Industry Chain Structure of Apomorphine Hydrochloride
Figure 76. Channels of Distribution
Figure 77. Global Apomorphine Hydrochloride Sales Market Forecast by Region (2026-2031)
Figure 78. Global Apomorphine Hydrochloride Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Apomorphine Hydrochloride Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Apomorphine Hydrochloride Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Apomorphine Hydrochloride Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Apomorphine Hydrochloride Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Foot Orthosis (FO) Market Growth 2023-2029
US$ 3,660.00
March 2023
107 pages
Global Kidney Transplant Surgery Instrument Market Growth 2023-2029
US$ 3,660.00
February 2023
105 pages
Global Colloids (Blood Plasma) Market Growth 2025-2031
US$ 3,660.00
March 2025
151 pages
Global Handheld Ultrasound System Market Growth 2023-2029
US$ 3,660.00
March 2023
117 pages
Global Botulinum Toxins Market Growth 2025-2031
US$ 3,660.00
August 2025
103 pages
